Skip to content

H.R. 2940 · 118th Congress (2023–2025)

PASTEUR Act

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $6 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

Show official title

To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 2940’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. IV Ferguson A. Drew (R-GA-3)
Cosponsors
62 cosponsors

3 original · 59 later

31 R · 31 D

  1. Rep. Jake LaTurner (R-KS-2)· Original · Apr 27, 2023
  2. Rep. Mike Levin (D-CA-49)· Original · Apr 27, 2023
  3. Rep. Scott H. Peters (D-CA-50)· Original · Apr 27, 2023
  4. Rep. Mark E. Amodei (R-NV-2)· Later · Apr 28, 2023
  5. Rep. James P. McGovern (D-MA-2)· Later · May 2, 2023
  6. Rep. Jake Auchincloss (D-MA-4)· Later · May 10, 2023
  7. Rep. Don Bacon (R-NE-2)· Later · May 10, 2023
  8. Rep. Yvette D. Clarke (D-NY-9)· Later · May 10, 2023
  9. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · May 10, 2023
  10. Rep. Donald G. Davis (D-NC-1)· Later · May 10, 2023
  11. Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Later · May 10, 2023
  12. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · May 10, 2023
  13. Del. Eleanor Holmes Norton (D-DC)· Later · May 10, 2023
  14. Rep. Jimmy Panetta (D-CA-19)· Later · May 10, 2023
  15. Rep. Deborah K. Ross (D-NC-2)· Later · May 10, 2023
  16. Rep. Maria Elvira Salazar (R-FL-27)· Later · May 10, 2023
  17. Rep. Austin Scott (R-GA-8)· Later · May 10, 2023
  18. Rep. Lisa Blunt Rochester (D-DE)· Later · May 18, 2023
  19. Rep. Troy A. Carter (D-LA-2)· Later · May 18, 2023
  20. Rep. Jeff Duncan (R-SC-3)· Later · May 18, 2023
  21. Rep. Mike Kelly (R-PA-16)· Later · May 18, 2023
  22. Rep. Ann M. Kuster (D-NH-2)· Later · May 18, 2023
  23. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · May 18, 2023
  24. Res. Comm. Jenniffer González-Colón (R-PR)· Later · May 22, 2023
  25. Rep. Doris O. Matsui (D-CA-7)· Later · May 22, 2023
  26. Rep. Adrian Smith (R-NE-3)· Later · May 22, 2023
  27. Rep. Paul Tonko (D-NY-20)· Later · May 22, 2023
  28. Rep. Diana DeGette (D-CO-1)· Later · Jun 14, 2023
  29. Rep. David G. Valadao (R-CA-22)· Later · Jun 14, 2023
  30. Rep. Nanette Diaz Barragán (D-CA-44)· Later · Jun 21, 2023
  31. Rep. Gregory F. Murphy (R-NC-3)· Later · Jun 21, 2023
  32. Rep. David Schweikert (R-AZ-1)· Later · Jun 21, 2023
  33. Rep. Kim Schrier (D-WA-8)· Later · Jun 21, 2023
  34. Rep. Angie Craig (D-MN-2)· Later · Jun 22, 2023
  35. Rep. Mark E. Green (R-TN-7)· Later · Jun 22, 2023
  36. Rep. Mike Carey (R-OH-15)· Later · Jun 27, 2023
  37. Rep. Bill Johnson (R-OH-6)· Later · Jun 30, 2023
  38. Rep. Daniel Meuser (R-PA-9)· Later · Jun 30, 2023
  39. Rep. Mike Quigley (D-IL-5)· Later · Jun 30, 2023
  40. Rep. Jamie Raskin (D-MD-8)· Later · Jun 30, 2023
  41. Rep. Larry Bucshon (R-IN-8)· Later · Jul 10, 2023
  42. Rep. Daniel S. Goldman (D-NY-10)· Later · Jul 10, 2023
  43. Rep. Terri A. Sewell (D-AL-7)· Later · Jul 12, 2023
  44. Rep. Jefferson Van Drew (R-NJ-2)· Later · Jul 12, 2023
  45. Rep. Michael C. Burgess (R-TX-26)· Later · Jul 25, 2023
  46. Rep. Susie Lee (D-NV-3)· Later · Jul 25, 2023
  47. Rep. Lucy McBath (D-GA-7)· Later · Sep 14, 2023
  48. Rep. Jay Obernolte (R-CA-23)· Later · Sep 14, 2023
  49. Rep. John B. Larson (D-CT-1)· Later · Sep 26, 2023
  50. Rep. Tracey Mann (R-KS-1)· Later · Sep 26, 2023
  51. Rep. Juan Ciscomani (R-AZ-6)· Later · Nov 2, 2023
  52. Rep. Lori Trahan (D-MA-3)· Later · Nov 2, 2023
  53. Rep. Nicole Malliotakis (R-NY-11)· Later · Nov 29, 2023
  54. Rep. Joe Neguse (D-CO-2)· Later · Nov 29, 2023
  55. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Jan 29, 2024
  56. Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Jan 29, 2024
  57. Rep. Henry Cuellar (D-TX-28)· Later · Feb 9, 2024
  58. Rep. Brad R. Wenstrup (R-OH-2)· Later · Feb 9, 2024
  59. Rep. Ben Cline (R-VA-6)· Later · Mar 6, 2024
  60. Rep. Jason Crow (D-CO-6)· Later · Mar 6, 2024
  61. Rep. Frank J. Mrvan (D-IN-1)· Later · May 21, 2024
  62. Rep. Christopher H. Smith (R-NJ-4)· Later · May 21, 2024
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Advanced technology and technological innovations
  • Advisory bodies
  • Appropriations
  • Department of Health and Human Services
  • Drug therapy
  • Executive agency funding and structure
  • Government information and archives
  • 7 more
    • Government studies and investigations
    • Health information and medical records
    • Infectious and parasitic diseases
    • Medical research
    • Prescription drugs
    • Public contracts and procurement
    • Research and development

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 3 committee actions · Apr 27, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseBudgetReferred Apr 27, 2023
  2. HouseOversight and AccountabilityReferred Apr 27, 2023
  3. HouseEnergy and CommerceReferred Apr 27, 2023
  4. HouseHealthReferred Apr 28, 2023
  5. HouseWays and MeansReferred Apr 27, 2023
  6. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. PASTEUR Act

    Display title, Short title · Introduced in House

  2. Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023

    Short title · Introduced in House

  3. To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.

    Official title · Introduced in House